Full Paper
(m, 10 H), 6.83–6.74 (m, 1 H), 6.51–6.46 (m, 1 H), 6.39–6.32 (m, 3 H),
6.07–5.96 (m, 4 H), 5.82 (dd, J = 15.3, 7.1 Hz, 1 H), 4.73 (dd, J = 7.4,
2.6 Hz, 1 H), 4.67–4.63 (m, 5 H), 4.55–4.49 (m, 2 H), 3.90–3.86 (m, 2
H), 1.51 (s, 3 H), 1.49 (s, 3 H), 1.33 (s, 3 H), 1.32 (s, 3 H) ppm. 13C
NMR (75 MHz, CDCl3): major isomer: δ = 137.4, 130.4, 129.0, 128.5,
127.9, 127.6, 127.3, 119.5, 111.7, 104.9, 83.6, 82.7, 80.9, 72.2, 26.8,
26.2 ppm. MS (ESI+-TOF): m/z (%) = 339 (35, 37Cl) [M + H]+, 337
(100, 35Cl) [M + H]+. HRMS (ESI+): calcd. for C18H2235ClO4 [M + H]+
337.1201; found 317.1239.
The resulting residue was purified by column chromatography (sil-
ica gel, hexane/EtOAc).
(6E)-1,2:3,4-Di-O-isopropylidene-9-C-phenyl-6,7,8,9-tetrade-
oxy-β-D-galacto-nona-6-en-8-ynopyranose (5b): Yellow oil.
1
[α]D22 = +4.6 (c = 0.6, CHCl3). Rf = 0.31 (hexane/EtOAc, 8:1). H NMR
(300 MHz, CDCl3): δ = 7.42–7.39 (m, 2 H), 7.33–7.26 (m, 3 H), 6.11
(dd, J = 11.0, 8.0 Hz, 1 H, 8-H), 5.90 (dd, J = 11.0, 1.0 Hz, 1 H, 7-H),
5.58 (d, J = 5.0 Hz, 1 H, 1-H), 5.01 (dd, J = 8.0, 2.0 Hz, 1 H, 5-H), 4.67
(dd, J = 7.9, 2.5 Hz, 1 H, 3-H), 4.39–4.44 (m, 2 H, 2-H, 4-H), 1.57 (s, 3
H), 1.50 (s, 3 H), 1.35 (s, 3 H), 1.34 (s, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 138.7, 131.4, 128.4, 128.3, 122.9, 111.4, 109.3, 108.9, 96.4,
95.1, 85.2, 73.2, 70.8, 70.3, 67.0, 26.1, 25.9, 25.0, 24.3 ppm. MS (ESI+-
TOF): m/z (%) = 357 (4) [M + Na]+, 241 (100). HRMS (ESI+): calcd. for
C21H25O5 [M + H]+ 357.1696; found 357.1707.
3-[(1E)-4-Chlorobuta-1,3-dien-1-yl]-6-methyl-4H-chromen-4-
one (4j): Yellow oil. Rf = 0.38 (hexane/EtOAc, 9:1). 1H NMR (300 MHz,
CDCl3): δ = 8.08–7.96 (m, 4 H), 7.79–7.33 (m, 6 H), 6.66–6.31 (m, 5
H), 6.09 (d, J = 7.1 Hz, 1 H), 2.46 (s, 3 H, CH3) ppm. 13C NMR (75 MHz,
CDCl3): major isomer: δ = 176.5, 159.3, 153.7, 135.4, 134.9, 134.4,
128.3, 125.5, 123.8, 123.7, 121.7, 117.8, 21.0 ppm. MS (ESI+-TOF): m/z
(%) = 249 (35, 37Cl) [M + H]+, 248 (15), 247 (100, 35Cl) [M + H]+. HRMS
(ESI+): calcd. for C14H1237ClO2 [M + H]+ 249.0491; found 249.0487.
General Procedure for the Kumada Reaction (Method C): A reac-
tion flask containing the corresponding chlorodiene 4 (1 equiv.) and
[Pd(PPh3)4] (5 mol-%) was degassed and filled with argon. DMF
(5 mL/mmol) and Et3N (3 equiv.) were added followed by phenyl-
magnesium bromide (2 equiv.). After stirring at room temp. for 1 h,
the mixture was quenched with an aqueous saturated solution of
NH4Cl (8 mL/mmol) and extracted with Et2O (5 mL/mmol). The com-
bined organic extracts were washed with H2O (5 mL/mmol) and
brine (5 mL/mmol), dried (Na2SO4) and concentrated to dryness.
The resulting residue was purified by column chromatography (sil-
ica gel, hexane/EtOAc).
General Procedure for the Suzuki Reaction (Method A): A reac-
tion flask containing the corresponding bromo alkene 2 (1 equiv.),
Ph3P (0.2 equiv.), Pd(OAc)2 (5 mol-%), K2CO3 (1.5 equiv.) and phenyl-
boronic acid (1.2 equiv.) was degassed and filled with argon. DMF
(5 mL/mmol) was added and the resulting mixture was stirred at
70 °C. After 12 h, the reaction mixture was diluted with H2O (8 mL/
mmol) and extracted with Et2O (5 mL/mmol). The combined or-
ganic extracts were washed with H2O (5 mL/mmol) and brine (5 mL/
mmol), dried (Na2SO4) and concentrated to dryness. The resulting
residue was purified by column chromatography (silica gel, hexane/
EtOAc).
(6E,8E)-1,2:3,4-Di-O-isopropylidene-9-C-phenyl-6,7,8,9-tetra-
deoxy-β-D-galacto-nona-6,8-dieno-1,5-pyranose (5c): Yellow oil.
1
Rf = 0.38 (hexane/EtOAc, 9:1). H NMR (300 MHz, CDCl3): δ = 7.34–
7.26 (m, 10 H), 6.92–6.79 (m, 2 H), 6.59–6.26 (m, 4 H), 5.98–5.90 (m,
2 H), 5.61–5.56 (m, 2 H), 4.63–4.60 (m, 2 H), 4.36–4.30 (m, 4 H), 4.24–
4.21 (m, 2 H), 1.56 (s, 3 H), 1.52 (s, 3 H), 1.49 (s, 3 H), 1.46 (s, 3 H),
1.38 (s, 3 H), 1.36 (s, 3 H), 1.35 (s, 3 H), 1.33 (s, 3 H) ppm. 13C NMR
(75 MHz, CDCl3): major isomer: δ = 137.4, 131.2, 130.5, 129.6, 129.0,
128.2, 127.0, 115.3, 109.3, 108.5, 96.4, 73.5, 70.9, 70.4, 68.7, 26.1,
26.0, 24.9, 24.3 ppm. MS (ESI+-TOF): m/z (%) = 359 (100) [M + H]+,
358 (12) [M]+. HRMS (ESI+): calcd. for C21H27O5 [M + H]+ 359.1853;
found 359.1853.
(6E)-6,7-Dideoxy-1,2:3,4-di-O-isopropylidene-7-C-phenyl-β-D-
galacto-hept-6-enopyranose (5a): [α]D22 = +32.1 (c = 2.1, CHCl3).
1
Rf = 0.31 (hexane/EtOAc, 8:1). H NMR (300 MHz, CDCl3): δ = 7.43–
7.40 (m, 2 H), 7.32–7.22 (m, 3 H), 6.68 (d, J = 15.8 Hz, 1 H, 7-H), 6.31
(dd, J = 15.8, 6.7 Hz, 1 H, 6-H), 5.62 (d, J = 5.0 Hz, 1 H, 1-H), 4.65
(dd, J = 7.8, 2.3 Hz, 1 H, 3-H), 4.35 (dd, J = 5.0, 2.3 Hz, 1 H, 2-H),
4.46–4.44 (m, 1 H, 5-H), 4.28 (dd, J = 7.8, 2.0 Hz, 1 H, 4-H), 1.57 (s,
3 H), 1.50 (s, 3 H), 1.35 (s, 3 H), 1.34 (s, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 136.1, 129.0, 128.7, 128.5, 128.2, 127.8, 111.4, 109.1, 96.2,
73.1, 70.9, 70.2, 69.4, 26.1, 26.0, 25.0, 24.5 ppm. MS (ESI+-TOF): m/z
(%) = 355 (23) [M + Na]+, 333 (41) [M + H]+. HRMS (ESI+): calcd. for
C19H24NaO5 [M + Na]+ 355.1516; found 355.1519.
(5E,7E)-3-O-Benzyl-1,2-O-isopropylidene-8-phenyl-5,6,7,8-
tetradeoxy-α-D-xylo-oct-5,7-dieno-1,4-furanose (5g): Yellow oil.
1
Rf = 0.38 (hexane/EtOAc, 9:1). H NMR (300 MHz, CDCl3): δ = 7.37–
7.26 (m, 20 H), 6.83–6.74 (m, 1 H), 6.66–6.46 (m, 1 H), 6.39–6.21 (m,
2 H), 6.07–5.94 (m, 5 H), 5.90–5.76 (m, 1 H), 4.74–4.50 (m, 8 H), 3.90
(d, J = 3.2 Hz, 1 H), 3.86 (d, J = 3.1 Hz, 1 H), 1.51 (s, 3 H), 1.49 (s, 3
H), 1.33 (s, 3 H), 1.32 (s, 3 H) ppm. 13C NMR (75 MHz, CDCl3): major
isomer: δ = 137.4, 130.4, 129.0, 128.5, 127.9, 127.6, 127.3, 119.5,
111.7, 104.9, 83.6, 82.9, 80.9, 72.2, 26.8, 26.2 ppm. MS (ESI+-TOF):
m/z (%) = 379 (25) [M + H]+, 123 (100). HRMS (ESI+): calcd. for
C24H27O4 [M + H]+ 379.1904; found 379.1938.
Methyl (6E)-2,3,4-Tri-O-benzyl-7-C-phenyl-6,7-dideoxy-α-D-
manno-hept-6-enepyranoside (5e): Pale-yellow oil. [α]D22 = +2.4
(c = 0.4, CHCl3). Rf = 0.26 (hexane/EtOAc, 9:1). 1H NMR (300 MHz,
CDCl3): δ = 7.30–7.20 (m, 20 H), 6.75 (d, J = 15.9 Hz, 1 H, 7-H), 6.33
(dd, J = 15.9, 7.0 Hz, 1 H, 6-H), 4.84–4.59 (m, 7 H, 3 OCH2Ph, 2-H),
4.19 (dd, J = 9.0, 7.0 Hz, 1 H, 5-H), 3.94–3.79 (m, 3 H, 2-H, 3-H, 4-H),
3.32 (s, 3 H, OCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 138.7, 138.3,
133.8, 133.1, 128.6, 128.4, 128.3, 128.0, 127.7, 127.6, 127.5, 126.8,
126.6, 99.4, 80.0, 78.9, 75.4, 74.9, 73.0, 72.9, 72.6, 54.9 ppm. MS
(ESI+-TOF): m/z (%) = 559 (100) [M + Na]+. HRMS (ESI+): calcd. for
C35H36NaO5 [M + Na]+ 559.2455; found 559.2423;
General Procedure for the Stille Reaction (Method D): A reaction
flask containing the corresponding bromo alkene 2 (1 equiv.) in
DMF (5 mL/mmol) was degassed and filled with argon. Ph3P
(0.2 equiv.) and Pd(OAc)2 (5 mol-%) were added, followed by tri-
butyl(vinyl)stannane (1.1 equiv.). After stirring at 60 °C for 10 h, the
reaction mixture was diluted with H2O (8 mL/mmol) and extracted
with EtOAc (5 mL/mmol). The combined organic extracts were
washed with H2O (5 mL/mmol) and brine (5 mL/mmol), dried
(Na2SO4) and concentrated to dryness.
General Procedure for the Sonogashira Reaction (Method B): A
reaction flask containing the corresponding bromo alkene 2
(1 equiv.), Ph3P (0.2 equiv.), Pd(OAc)2 (5 mol-%) and CuI (5 mol-%)
was degassed and filled with argon. DMF (5 mL/mmol) and iPr2NH
(2.5 mL/mmol) were added followed by ethynylbenzene (1.2 equiv.).
After stirring at room temp. for 10 h, the mixture was diluted with
H2O (8 mL/mmol) and extracted with Et2O (5 mL/mmol). The com- (5E)-1-O-tert-Butyldimethylsilyl-2,3-O-isopropylidene-5,6,7,8-
bined organic extracts were washed with H2O (5 mL/mmol) and
brine (5 mL/mmol), dried (Na2SO4) and concentrated to dryness.
tetradeoxy-α-D-lyxo-oct-5,7-dieno-1,4-furanose (5d): Colourless
oil. [α]D22 = –27.5 (c = 1.2, CHCl3). Rf = 0.27 (hexane/EtOAc, 9:1). 1H
Eur. J. Org. Chem. 2016, 99–107
105
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim